Immix BiopharmaIMMX
13F holders, Q3 2025 (September 30)At the end of Q3 2025, 31 institutions reported holding Immix Biopharma Inc. (IMMX) in their 13F filings, up 8 from Q2 2025. 11 opened new positions and 4 sold out. The largest holders were Bleichroeder LP ($1.8M), Vanguard Group Inc. ($1.5M) and Geode Capital Management, LLC ($392K). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Immix Biopharma Inc.
- CUSIP
- 45258H106
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 11 | $646K |
| Exits | 4 | $61K |
All 13F filers, Q2 2025 → Q3 2025: 486,942 shares bought and 50,665 shares sold, net +436,277 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 31 holders
| Bleichroeder LP | 0.35% | No change | 850,000 | $1.8M |
| Vanguard Group Inc. | 0.00% | Add +4.5% | 730,162 | $1.5M |
| Geode Capital Management, LLC | 0.00% | Add +16.4% | 187,476 | $392K |
| Morgan Stanley | 0.00% | Reduce -3.4% | 120,670 | $252K |
| State Street Corp. | 0.00% | Add +130.3% | 98,960 | $207K |
| Susquehanna International Group, LLP | 0.00% | Add +78.8% | 90,858 | $190K |
| Citadel Advisors | 0.00% | New | 89,798 | $188K |
| Northern Trust Corp. | 0.00% | Reduce -4.9% | 89,301 | $187K |
| United Capital Financial Advisors, LLC | 0.00% | New | 70,682 | $148K |
| Imprint Wealth LLC | 0.45% | — | 67,423 | $141K |
| Marshall Wace, LLP | 0.00% | New | 55,035 | $115K |
| BlackRock, Inc. | 0.00% | Add +6.9% | 43,068 | $90K |
| Tocqueville Asset Management L.P. | 0.00% | Add +37.4% | 40,250 | $84K |
| XTX Topco Ltd | 0.00% | New | 35,153 | $73K |
| Velan Capital Investment Management LP | 0.07% | Add +40.0% | 35,000 | $73K |
| Private Advisor Group, LLC | 0.00% | No change | 31,225 | $65K |
| Tritonpoint Wealth, LLC | 0.00% | No change | 24,526 | $51K |
| Renaissance Technologies | 0.00% | New | 21,500 | $45K |
| SBI Securities Co., Ltd. | 0.00% | No change | 17,500 | $37K |
| Commonwealth Equity Services, LLC | 0.00% | No change | 16,040 | $34K |
| Jane Street Group, LLC | 0.00% | New | 14,970 | $31K |
| Focus Partners Wealth | 0.00% | No change | 11,900 | $25K |
| Snowden Capital Advisors LLC | 0.00% | New | 10,000 | $21K |
| CIBC Private Wealth Group LLC | 0.00% | New | 10,000 | $21K |
| MAI Capital Management | 0.00% | New | 2,000 | $4K |
| UBS Group AG | 0.00% | Reduce -86.1% | 1,940 | $4K |
| Wells Fargo & Company | 0.00% | No change | 330 | $690 |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 80 | $167 |
| Citigroup Inc. | 0.00% | New | 35 | $73 |
| Arax Advisory Partners | 0.00% | New | 34 | $71 |
| Bank of America Corp. | 0.00% | Reduce -91.4% | 12 | $25 |
"% of holder's portfolio" is IMMX's weight in each manager's 13F, not the share of Immix Biopharma Inc. the manager owns.